Qiagen's high P/E ratio is worrisome due to its poor earnings forecast. Despite the high P/E, investors retain their shares, but this earnings growth rate may eventually impact the share price. The high P/E and future earnings predictions pose a substantial risk to shareholders and potential investors.
快而精醫藥股票討論區
2023Q1營收下滑22.8%,營業利潤大幅下滑52%,淨利潤下滑45.3%,這已經是連續第四個季度營收和利潤下滑。
目前市盈率24.9,市盈率TTM已經上升到29.7,暫時缺乏吸引力。
縫隙漲幅
1. $SolarEdge Technologies (SEDG.US)$ 漲幅為7.31%
2. $柯爾百貨 (KSS.US)$ 漲幅為4.46%
3. $杜邦 (DD.US)$ 漲幅為4.38%
4. $Welltower (WELL.US)$ 漲幅為4.02%
5. $凱斯紐 (CNHI.US)$ - 猜漲跌3.18%
6. $Planet Fitness (PLNT.US)$ - 猜漲跌3.46%
7. $快而精醫藥 (QGEN.US)$ 猜漲跌2.35%
8. $台積電 (TSM.US)$ 上漲2.05...
$快而精醫藥 (QGEN.US)$ +3.4%(該生物技術公司提高了全年展望,指出其非Covid產品組合的特殊強勢)
$Lordstown Motors (RIDE.US)$ +14.6%(代工廠商Foxconn將投資最多17000萬美元於電動車製造商,並成為其最大股東。)
$杜邦 (DD.US)$ +3.7%(該工業材料製造商超出第三季度的收入和利潤預期。DuPont...
對盈利/指引的反應:
• $Bowlero (BOWL.US)$ +3.4%
其他資訊:
• $Intellia Therapeutics (NTLA.US)$ 壓力位上漲10.8%(第二個全身遞送的CRISPR候選NTLA-2002的暫時臨床資料)
• $Gogo Inc (GOGO.US)$ 上漲5%(從貝萊德回購150萬股普通股份)
• $ADC Therapeutics (ADCT.US)$ +2.9%(adc therapeutics與瑞典奧丁生物醫療(BIOVF)確認CHm陽性...
暫無評論